A review of cancer immunotherapy toxicity.
Kennedy LB, Salama AKS.
CA Cancer J Clin. 2020 Mar;70(2):86-104. doi: 10.3322/caac.21596. Epub 2020 Jan 16.
Cancer and the Immune System: The History and Background of Immunotherapy.
Abbott M, Ustoyev Y.
Semin Oncol Nurs. 2019 Oct;35(5):150923. doi: 10.1016/j.soncn.2019.08.002. Epub 2019 Sep 13.
Cancer immunotherapies: advances and bottlenecks.
Rui R, Zhou L, He S.
Front Immunol. 2023 Aug 24;14:1212476. doi: 10.3389/fimmu.2023.1212476. eCollection 2023.
Delivery technologies for cancer immunotherapy.
Riley RS, June CH, Langer R, Mitchell MJ.
Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z.
The hallmarks of cancer immune evasion.
Galassi C, Chan TA, Vitale I, Galluzzi L.
Cancer Cell. 2024 Nov 11;42(11):1825-1863. doi: 10.1016/j.ccell.2024.09.010. Epub 2024 Oct 10.
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy.
Hines JB, Kacew AJ, Sweis RF.
Curr Oncol Rep. 2023 Mar;25(3):189-199. doi: 10.1007/s11912-023-01361-0. Epub 2023 Jan 27.
Cancer Immunotherapy.
Bergman PJ.
Vet Clin North Am Small Anim Pract. 2024 May;54(3):441-468. doi: 10.1016/j.cvsm.2023.12.002. Epub 2023 Dec 28.
Immunotherapy: a promising approach for glioma treatment.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H.
Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023.
Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H.
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
New Approaches on Cancer Immunotherapy.
Cha JH, Chan LC, Song MS, Hung MC.
Cold Spring Harb Perspect Med. 2020 Aug 3;10(8):a036863. doi: 10.1101/cshperspect.a036863.
